Abstract
Alterations of nuclear proteins p53 and retinoblastoma protein (pRb) expression have been suggested to be predictive of tumour recurrence and progression in patients with superficial transitional cell carcinoma (TCC) of the bladder. We conducted a prospective study to determine the correlation between p53 and pRb expression, and the clinical outcome of superficial bladder TCC patients treated with intravesical BCG.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
